Bausch Health Americas, Inc.
Clinical trials sponsored by Bausch Health Americas, Inc., explained in plain language.
-
New drug formulation aims to postpone brain fog in cirrhosis patients
Disease control OngoingThis study tests whether a new version of the drug rifaximin can delay the first episode of overt hepatic encephalopathy (brain confusion) in people with liver cirrhosis who have fluid buildup controlled by medication. About 466 adults aged 18-85 with cirrhosis and no recent seve…
Phase: PHASE3 • Sponsor: Bausch Health Americas, Inc. • Aim: Disease control
Last updated Apr 26, 2026 20:03 UTC
-
Acne gel study: will patients stick with it?
Symptom relief OngoingThis study tracks about 200 people aged 12 and older with acne who use a prescription gel containing three active ingredients. Researchers want to see how satisfied patients are, how well they follow the treatment, and how it affects their quality of life over 20 weeks. The goal …
Sponsor: Bausch Health Americas, Inc. • Aim: Symptom relief
Last updated Apr 26, 2026 20:03 UTC
-
Psoriasis drug safety under the microscope: 3,500 patients tracked
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 3,500 adults with moderate-to-severe psoriasis to compare the long-term safety of the drug brodalumab against other psoriasis treatments. Researchers are tracking how many people develop cancer (excluding common skin cancers) while on brodalumab versus other bi…
Sponsor: Bausch Health Americas, Inc. • Aim: Knowledge-focused
Last updated Apr 26, 2026 20:01 UTC